Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
03 ›
321 PROGRAM
Trademark search for:
321 PROGRAM
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-11-19 — Application filed
2020-11-23 — Application filed
2021-01-25 — Application filed
2021-01-26 — Notice of design search code e-mailed
2021-05-03 — Final disposition recorded
2021-05-03 — Final disposition recorded
2021-05-03 — Assigned to examiner
2021-05-03 — Final disposition recorded
2021-11-02 — Teas/email correspondence entered
2021-11-02 — Office action issued
2021-11-02 — Correspondence received in law office
2021-11-18 — Office action issued
2021-11-18 — Office action issued
2021-11-18 — Office action issued
2022-05-18 — Teas request for reconsideration received
2022-05-23 — Assigned to lie
2022-05-27 — Teas/email correspondence entered
2022-05-27 — Correspondence received in law office
2022-06-02 — Approved for pub - principal register
2022-06-15 — Notification of notice of publication e-mailed
2022-07-05 — Published for opposition
2022-07-05 — Official gazette publication confirmation e-mailed
2022-08-30 — Noa e-mailed - sou required from applicant
2023-04-03 — Application abandoned
2023-04-03 — Application abandoned
2023-04-03 — Final status recorded
Owner Information
Previnex, LLC
New York , NY
Previnex, LLC
New York , NY
Correspondent
Edward Price ALWARD FISHER RICE ROWE AND GRAF 202 E. STATE STREET, SUITE 100 TRAVERSE CITY, MI 49684 UNITED STATES
Filing Details
Filing Date:
2020-11-19
Status Date:
2023-04-03
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.